ArticleScientific reports2026
Impact of herbal medicine use on HbA1c levels among type 2 diabetes mellitus patients in northwest Ethiopia.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Herbal medicine use is widespread among individuals with type 2 diabetes mellitus (T2DM), yet its influence on glycemic control remains uncertain. This study aimed to assess the prevalence of herbal medicine use and its association with glycemic control among adults with T2DM. A cross-sectional study was conducted from January to June 2025 among 420 adults with T2DM selected through systematic random sampling. Data were collected using structured interviews and medical record reviews. Glycemic control was assessed based on glycated hemoglobin (HbA1c) levels, with HbA1c < 7% considered good control. Descriptive statistics summarized sociodemographic and clinical characteristics. Associations between herbal use and glycemic control were examined using multivariable logistic regression analyses, with p < 0.05 denoting statistical significance. Of 420 participants, 223 (53.0%) were female, and the majority resided in urban areas (67.4%). Most (74.8%) had lived with diabetes for more than five years, and one-third (33.3%) had comorbidities. Herbal medicine use was reported by 219 (52.1%) participants, predominantly Moringa oleifera (61.6%), Trigonella foenum-graecum (45.7%), and Allium sativum (38.8%). Overall, 228 (54.3%) participants achieved good glycemic control (HbA1c < 7.0%), while the remaining 192 (45.7%) exhibited poor glycemic control (HbA1c ≥ 7.0%). In multivariable logistic regression, urban residence (AOR = 10.5, 95% CI 4.9-22.7), shorter diabetes duration (< 5 years) (AOR = 10.18, 95% CI 4.46-23.23), absence of comorbidity (AOR = 2.58, 95% CI 1.58-4.21), and non-users (AOR = 3.89, 95% CI 2.38-6.38) were independently associated with good glycemic control. Literacy and age above 40 years were also significant predictors (p < 0.05). In conclusion, the prevalence of herbal medicine use was high among individuals with T2DM but was significantly associated with poor glycemic control.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.